ArticleRevista da Associacao Medica Brasileira (1992)2026
Investigation of the relationship between expression patterns of plasma microRNAs and pregnancy complications.
Article in Revista da Associacao Medica Brasileira (1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of the study was to determine the association between plasma expression levels of microRNAs (miRNAs; MIR126-3p; and MIR375-3p) and pregnancy complications.
methodsThis prospective study included 39 pregnant women who admitted to Obstetrics and Gynecology Polyclinic of Tokat Gaziosmanpasa University, Faculty of Medicine. 28 of these pregnant women were healthy, while 11 had pregnancy complications (five hypertensive disorders of pregnancy and six gestational diabetes). Hypertensive disorders include preeclampsia, gestational hypertension, and chronic hypertension. The study included pregnant women older than 18 years of age with singleton pregnancies and no history of cancer. Quantitative real time-polymerase chain reaction was used to determine the expression patterns of MIR126-3p and MIR375-3p in maternal plasma. Fold change (2-ΔΔCt) analysis was used to examine the microRNA expression patterns.
resultsMIR375-3p expression levels demonstrated a statistically significant difference between two groups. It was significantly lower in women with pregnancy complications than healthy pregnant women.
conclusionWe found that MIR375-3p might be a useful indicator for non-invasive diagnosis and play a crucial part in predicting pregnancy complications. Given the limited patient cohort, more research using bigger samples is required to validate our findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.